Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Retrophin Inc (RTRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 977,347
  • Shares Outstanding, K 41,413
  • Annual Sales, $ 164,250 K
  • Annual Income, $ -102,680 K
  • 60-Month Beta 1.02
  • Price/Sales 6.11
  • Price/Cash Flow N/A
  • Price/Book 3.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.64
  • Number of Estimates 2
  • High Estimate -0.64
  • Low Estimate -0.64
  • Prior Year -0.46
  • Growth Rate Est. (year over year) -39.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.34 +16.62%
on 02/22/19
24.69 -3.93%
on 03/19/19
+2.30 (+11.36%)
since 02/21/19
3-Month
19.77 +19.98%
on 01/28/19
24.69 -3.93%
on 03/19/19
+2.42 (+11.99%)
since 12/21/18
52-Week
19.77 +19.98%
on 01/28/19
33.00 -28.12%
on 08/31/18
-0.56 (-1.82%)
since 03/21/18

Most Recent Stories

More News
Best Relative Performance in the Biotechnology Industry Detected in Shares of Tg Therapeutics (TGTX , CYTK , RTRX , LGND , SPPI )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

TGTX : 7.39 (-0.81%)
CYTK : 8.84 (-13.25%)
RTRX : 23.73 (+0.55%)
Retrophin (RTRX) Reports Q4 Loss, Misses Revenue Estimates

Retrophin (RTRX) delivered earnings and revenue surprises of -10.53% and -0.98%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

RTRX : 23.73 (+0.55%)
Detailed Research: Economic Perspectives on KAR Auction Services, Spectrum Brands, Vertex Pharmaceuticals, The Kraft Heinz, comScore, and Retrophin -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of KAR Auction Services, Inc (NYSE:KAR),...

SPB : 56.40 (+2.71%)
SCOR : 21.56 (-1.51%)
KHC : 32.75 (+2.28%)
VRTX : 182.56 (+1.43%)
KAR : 49.72 (+3.20%)
RTRX : 23.73 (+0.55%)
Retrophin to Present at Upcoming Investor Conferences

Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive officer, will present at the following upcoming investor conferences in March:

RTRX : 23.73 (+0.55%)
Retrophin Recognizes Rare Disease Day(R) 2019 and Honors People Living with Rare Disease and Their Caregivers

Retrophin, Inc. (NASDAQ: RTRX) today joins the National Organization for Rare Disorders (NORD), the European Organisation for Rare Diseases (EURORDIS), and others worldwide to recognize Rare Disease Day...

RTRX : 23.73 (+0.55%)
Retrophin, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 26, 2019 / Retrophin, Inc. (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on February 26, 2019 at 4:30 PM Eastern...

RTRX : 23.73 (+0.55%)
Downtrend Call Working As Retrophin Inc Stock Falls 25.4% (RTRX)

SmarTrend identified a Downtrend for Retrophin Inc (NASDAQ:RTRX) on September 24th, 2018 at $27.82. In approximately 5 months, Retrophin Inc has returned 25.40% as of today's recent price of $20.75.

RTRX : 23.73 (+0.55%)
Shares of RTRX Down 22.9% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Retrophin Inc (NASDAQ:RTRX) on September 24th, 2018 at $27.82. In approximately 5 months, Retrophin Inc has returned 22.92% as of today's recent price of $21.44.

RTRX : 23.73 (+0.55%)
Retrophin to Report Fourth Quarter and Full Year 2018 Financial Results

Retrophin, Inc. (NASDAQ: RTRX) today announced it will report fourth quarter and full year 2018 financial results on Tuesday, February 26, 2019 after the close of the U.S. financial markets. The Company...

RTRX : 23.73 (+0.55%)
Ligand (LGND) Beats on Q4 Earnings & Sales, Raises '19 View

Ligand (LGND) beats earnings and sales estimates for the fourth quarter of 2018 and raises 2019 guidance.

LGND : 129.17 (+4.42%)
NVS : 93.66 (+0.19%)
AMGN : 191.89 (+0.40%)
RTRX : 23.73 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More Share

Trade RTRX with:

Business Summary

Retrophin is a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases for which there are currently no viable options for patients. The Company's approved products include Chenodal', Cholbam, and Thiola',...

See More

Key Turning Points

2nd Resistance Point 24.49
1st Resistance Point 24.05
Last Price 23.73
1st Support Level 23.35
2nd Support Level 23.09

See More

52-Week High 33.00
Fibonacci 61.8% 27.95
Fibonacci 50% 26.39
Fibonacci 38.2% 24.82
Last Price 23.73
52-Week Low 19.77

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar